Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Urogenital Neoplasms 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Laryngeal Diseases 1Genital Neoplasms, Male 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 8Cetuximab 6Radiotherapy 5Fluorouracil 4Docetaxel 4durvalumab 2Surveys and Questionnaires 2Pemetrexed 2Nivolumab 2Narrow Band Imaging 2Gemcitabine 2Gefitinib 2Drug Therapy 2tremelimumab 1pembrolizumab 1niraparib 1linrodostat 1dostarlimab 1X-Rays 1Surgical Flaps 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Modafinil 1Minocycline 1Metformin 1MLN 8237 1Ipilimumab 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Laryngeal Diseases × Chemical Fractionation × Clear all
NCT03656133 2026-02-20

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
55 enrolled 10 charts
Head & Neck

Laryngeal Diseases, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡